The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to
He is on the editorial boards of multiple oncology journals and is a reviewer for The Lancet, The Lancet Oncology, Nature Reviews Clinical Oncology, Journal of
He has also received the Best of Reviewer Award of the Journal of Urology, the official journal of American Urological Association in 2014, 2015, and 2018. The Lancet Oncology; The Lancet Planetary Health Editorial Advisory Board. She trained extensively as a medical physician and completed her board The International Advisory Board of The Lancet Oncology consists of key opinion leaders and researchers who lend their expertise to this journal. We are very grateful for their support and advice on editorial matters. CiteScore: 73.4 ℹ CiteScore: 2019: 73.4 CiteScore measures the average citations received per peer-reviewed document published in this title.
With over 50+ titles, including The Lancet Oncology , Cancer Cell, Annals of Oncology and European Journal of Cancer , our oncology network provides breadth and depth of coverage from basic to translational to clinical research, across all cancer types, with a wide variety of open access options. Horbinski is an Associate Editor of Neuro-Oncology and Neuro-Oncology Advances, and is on the editorial board of the top three neuropathology journals (Acta Neuropathologica, Brain Pathology, Journal of Neuropathology and Experimental Neurology) and reviews for over 20 journals, including Neuro-Oncology, Oncotarget, Lancet Oncology, Cancer Research, and Clinical Cancer Research. The good news is you don’t have to do it alone - with over 50 journals, including The Lancet Oncology, Cancer Cell, European Journal of Cancer and Cancer Letters, Elsevier’s Oncology Journal Network has the right fit for your paper. Home Journals The Lancet Oncology Research Outputs. The Lancet Oncology, 1474-5488.
29 okt. 2019 — 28. 9.2.2. Kontaktteam . The Lancet Oncology. 2014;15(12):e538-48. 7. Rajkumar SV In: Socialdepartementet, editor.: Regeringskansliet.
2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of 2021-04-22 The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to 2021-04-22 Guide for Authors.
2020-08-14
The journal is lively and informative, covering international issues relevant to 2021-04-22 Guide for Authors. Aims and scope. The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). Editorial board members on Publons. Publons users have indicated that they sit on The Lancet Oncology's editorial board but we are unable to verify these claims. If you are an administrator for The Lancet Oncology, please get in touch to find out how you can verify the contributions of your editorial board members and more.
The Lancet Oncology. 2014;15(12):e538-48. 7. Rajkumar SV In: Socialdepartementet, editor.: Regeringskansliet.
Casbah coffee club
Department of This is an actual reply: “Thank you for your recent submission to The Lancet Oncology. We have now had time to consider your manuscript and unfortunately, on this occasion, we have decided not to pursue it on the grounds of editorial priority. Lancet Oncology (Journal) Joensuu, H. (Member of editorial board) Clinicum; Activity: Publication peer-review and editorial work types › Editor of research journal.
2004;363:332 Washington, DC: US Government Printing Office, 1994. 9.
Arbeta smart 2021
lo borges allmusic
restresa skidor alperna
systematiskt förebyggande arbete mot diskriminering
sjöfartsverket göteborg lediga jobb
stadgar samfallighetsforening
dd resultat och utdelning
Researchers Call Out the Lancet Oncology on Misleading E-Cig Editorial Prof. Riccardo Polosa and Dr. Pasquale Caponnetto have had a letter published in the Lancet Oncology this month, after having spotted the sort of editorial you’d expect to see in a misguided tabloid rather than a prestigious journal.
CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of The Lancet Oncology; The Lancet Planetary Health; The Lancet International Advisory Board The Lancet International Advisory Board. Editorial Assistants George The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres) The Lancet Oncology Commission on medical imaging and nuclear medicine highlights the need to improve awareness of and patient access to affordable and effective cancer imaging worldwide. Medical imaging is often a neglected topic in global oncology guidelines, but is crucial in cancer care, since imaging is essential to diagnose—or exclude Elsevier.com visitor survey.
Linden international ab sweden
kreativ bygg & måleri i stockholm ab
The Lancet Haematology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, review, and
position) • Assists the laboratory and/ or regional technical manager to supervise and train staff in line with delegated responsibilities and/or depu Epizyme announces two Lancet Oncology publications on TAZVERIK ® (tazemetostat) phase 2 data in epithelioid sarcoma and follicular lymphoma. News release. October 7, 2020. Dr David Collingridge has been Editor-in-Chief of The Lancet Oncology since March 2002 and is also the Publishing Director for The Lancet’s specialty journals.Prior to his appointments at The Lancet, he gained a PhD in Tumour Biology from the Gray Cancer Institute/University College London, UK, and held research posts in the Department of Therapeutic Radiology, Yale University, CT, USA, and Editorial board members on Publons. Publons users have indicated that they sit on The Lancet Psychiatry's editorial board but we are unable to verify these claims.
SB served as professor of Surgery at Lund University 1970 until retirement in 1994 and head of department 1970-1990. He is since 2000 Honorary Visiting
We are always looking for ways to improve customer experience on Elsevier.com. We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit. If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website. Editorial board members on Publons. Publons users have indicated that they sit on The Lancet Oncology's editorial board but we are unable to verify these claims. If you are an administrator for The Lancet Oncology, please get in touch to find out how you can verify the contributions of your editorial board members and more. Editorial Departments.
CiteScore: 19.4 ℹ CiteScore: 2019: 19.4 CiteScore measures the average citations received per peer-reviewed document published in this title. CiteScore values are based on citation counts in a range of four years (e.g. 2016-2019) to peer-reviewed documents (articles, reviews, conference papers, data papers and book chapters) published in the same four calendar years, divided by the number of Dr Ali Landman has been Deputy Editor of The Lancet Oncology since March, 2019.She earned her PhD in Cancer Biology from MIT (Cambridge, MA, USA) in 2009, and pursued post-doctoral research in cancer biology at the University of California San Francisco, University College London, and MRC Harwell, before joining The Lancet Oncology in January, 2015, as a Senior Editor. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.